
226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred
The Readout Loud
00:00
Biotech IPO - Third Harmonic Bio
A company called Third Harmonic Bio, which price and offering raised $185 million. Damian: This is among the kind of like green shoots that we've discussed over the summer of biotech not recovering to where it was last year. But at least maybe stanching some of the bleeding that we saw earlier this year.
Transcript
Play full episode